37 related articles for article (PubMed ID: 31415805)
1. Zinc Salts Block Hepatitis E Virus Replication by Inhibiting the Activity of Viral RNA-Dependent RNA Polymerase.
Kaushik N; Subramani C; Anang S; Muthumohan R; Shalimar ; Nayak B; Ranjith-Kumar CT; Surjit M
J Virol; 2017 Nov; 91(21):. PubMed ID: 28814517
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of Hepatitis E Virus Spread by the Natural Compound Silvestrol.
Glitscher M; Himmelsbach K; Woytinek K; Johne R; Reuter A; Spiric J; Schwaben L; Grünweller A; Hildt E
Viruses; 2018 Jun; 10(6):. PubMed ID: 29865243
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic targets for the treatment of hepatitis E virus infection.
Kenney SP; Meng XJ
Expert Opin Ther Targets; 2015; 19(9):1245-60. PubMed ID: 26073772
[TBL] [Abstract][Full Text] [Related]
4. Three Distinct Reporter Systems of Hepatitis E Virus and Their Utility as Drug Screening Platforms.
Primadharsini PP; Nagashima S; Nishiyama T; Okamoto H
Viruses; 2023 Sep; 15(10):. PubMed ID: 37896767
[TBL] [Abstract][Full Text] [Related]
5. Quantification of host proteomic responses to genotype 4 hepatitis E virus replication facilitated by pregnancy serum.
Qian Z; Cong C; Li Y; Bi Y; He Q; Li T; Xia Y; Xu L; Mickael HK; Yu W; Liu J; Wei D; Huang F
Virol J; 2023 Jun; 20(1):111. PubMed ID: 37264422
[TBL] [Abstract][Full Text] [Related]
6. Could Histamine H1 Receptor Antagonists Be Used for Treating COVID-19?
Qu C; Fuhler GM; Pan Y
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34073529
[TBL] [Abstract][Full Text] [Related]
7. An Integrative Transcriptome-Wide Analysis of Amyotrophic Lateral Sclerosis for the Identification of Potential Genetic Markers and Drug Candidates.
Park S; Kim D; Song J; Joo JWJ
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33809961
[TBL] [Abstract][Full Text] [Related]
8. Drug Discovery in Liver Disease Using Kinome Profiling.
Yu B; Mamedov R; Fuhler GM; Peppelenbosch MP
Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33807722
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis E Virus Infection: Circulation, Molecular Epidemiology, and Impact on Global Health.
Pallerla SR; Harms D; Johne R; Todt D; Steinmann E; Schemmerer M; Wenzel JJ; Hofmann J; Shih JWK; Wedemeyer H; Bock CT; Velavan TP
Pathogens; 2020 Oct; 9(10):. PubMed ID: 33092306
[TBL] [Abstract][Full Text] [Related]
10. Drug screening identifies gemcitabine inhibiting rotavirus through alteration of pyrimidine nucleotide synthesis pathway.
Chen S; Wang Y; Li P; Yin Y; Bijvelds MJ; de Jonge HR; Peppelenbosch MP; Kainov DE; Pan Q
Antiviral Res; 2020 Aug; 180():104823. PubMed ID: 32485209
[TBL] [Abstract][Full Text] [Related]
11. Ribavirin as a First Treatment Approach for Hepatitis E Virus Infection in Transplant Recipient Patients.
Rivero-Juarez A; Vallejo N; Lopez-Lopez P; Díaz-Mareque AI; Frias M; Vallejo A; Caballero-Gómez J; Rodríguez-Velasco M; Molina E; Aguilera A
Microorganisms; 2019 Dec; 8(1):. PubMed ID: 31888090
[TBL] [Abstract][Full Text] [Related]
12. Niclosamide inhibits hepatitis E virus through suppression of NF-kappaB signalling.
Li Y; Li P; He Q; Zhang R; Li Y; Kamar N; Peppelenbosch MP; de Man RA; Wang L; Pan Q
Antiviral Res; 2022 Jan; 197():105228. PubMed ID: 34929248
[TBL] [Abstract][Full Text] [Related]
13. Drug screening identified gemcitabine inhibiting hepatitis E virus by inducing interferon-like response via activation of STAT1 phosphorylation.
Li Y; Li P; Li Y; Zhang R; Yu P; Ma Z; Kainov DE; de Man RA; Peppelenbosch MP; Pan Q
Antiviral Res; 2020 Dec; 184():104967. PubMed ID: 33137361
[TBL] [Abstract][Full Text] [Related]
14. Zinc: A Potential Antiviral Against Hepatitis E Virus Infection?
Kaushik N; Anang S; Ganti KP; Surjit M
DNA Cell Biol; 2018 Jul; 37(7):593-599. PubMed ID: 29897788
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis E Virus Mutations: Functional and Clinical Relevance.
van Tong H; Hoan NX; Wang B; Wedemeyer H; Bock CT; Velavan TP
EBioMedicine; 2016 Sep; 11():31-42. PubMed ID: 27528267
[TBL] [Abstract][Full Text] [Related]
16. FDA-drug screening identifies deptropine inhibiting hepatitis E virus involving the NF-κB-RIPK1-caspase axis.
Qu C; Li Y; Li Y; Yu P; Li P; Donkers JM; van de Graaf SFJ; de Man RA; Peppelenbosch MP; Pan Q
Antiviral Res; 2019 Oct; 170():104588. PubMed ID: 31415805
[TBL] [Abstract][Full Text] [Related]
17. Isocotoin suppresses hepatitis E virus replication through inhibition of heat shock protein 90.
Nimgaonkar I; Archer NF; Becher I; Shahrad M; LeDesma RA; Mateus A; Caballero-Gómez J; Berneshawi AR; Ding Q; Douam F; Gaska JM; Savitski MM; Kim H; Ploss A
Antiviral Res; 2021 Jan; 185():104997. PubMed ID: 33326835
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
